Skip to content
PeptideFactSheets

Related frontier molecules

Beyond peptides—without blurring the science.

NAD+, metformin, rapamycin, and other frontier molecules belong in the conversation, but not in the peptide category. Browse their regulatory status, human evidence, risks, and unknowns here.

Filter the companion library

Showing 13 of 13 molecule fact sheets

Not FDA approved

Cellular coenzyme

NAD+

A central cellular coenzyme with legitimate biology but little clinical-outcomes evidence for wellness infusions.

Healthy agingMitochondrial health
Limited or unclear evidence
Read molecule fact sheet
Not FDA approved

Vitamin B3-related NAD+ precursor

Nicotinamide riboside

An NAD+ precursor that reliably changes biomarkers but has not shown a consistent anti-aging or cognitive benefit.

Healthy agingMitochondrial health
Early human evidence
Read molecule fact sheet
Not FDA approved

NAD+ precursor

Nicotinamide mononucleotide

An NAD+ precursor with small human trials and unresolved real-world clinical value.

Healthy agingMitochondrial health
Early human evidence
Read molecule fact sheet
FDA approved for specific uses

mTOR-inhibiting medicine

Sirolimus

An FDA-approved immunosuppressant with serious risks and unproven longevity use in healthy people.

Healthy agingImmune and infection
Strong human evidence for approved uses
Read molecule fact sheet
FDA approved for specific uses

Biguanide medicine

Metformin

A foundational diabetes medicine being studied in geroscience, without an approved anti-aging use.

Metabolic healthHealthy aging
Strong human evidence for approved uses
Read molecule fact sheet
Not FDA approved

Gut-microbiome-derived metabolite

Urolithin A

A mitophagy-related metabolite with human biomarker and muscle-endurance signals but no approved disease use.

Mitochondrial healthMuscle and performance
Early human evidence
Read molecule fact sheet
Not FDA approved

Naturally occurring polyamine

Spermidine

A food-derived polyamine linked to autophagy biology, with a negative phase 2 cognitive primary outcome.

Healthy agingCognition and brain
Early human evidence
Read molecule fact sheet
In clinical trials

Flavonoid and experimental senolytic

Fisetin

A plant flavonoid with striking mouse senolytic findings but no proven human longevity or frailty benefit.

Healthy agingCellular senescence
Mostly animal or lab research
Read molecule fact sheet
In clinical trials

Investigational senolytic drug combination

Dasatinib plus quercetin

An experimental senolytic pairing that combines a serious cancer medicine with a flavonoid.

Healthy agingCellular senescence
Early human evidence
Read molecule fact sheet
In clinical trials

Energy-cycle metabolite

Alpha-ketoglutarate

A central metabolic intermediate with mouse healthspan findings and unfinished human geroscience questions.

Healthy agingMetabolic health
Mostly animal or lab research
Read molecule fact sheet
Not FDA approved

Amino sulfonic acid

Taurine

A common nutrient-related molecule whose animal longevity story is challenged by newer human aging data.

Healthy agingMuscle and performance
Limited or unclear evidence
Read molecule fact sheet
Not FDA approved

Cellular energy-buffering compound

Creatine

A well-studied performance supplement with credible muscle evidence and a less certain cognitive-aging frontier.

Muscle and performanceCognition and brain
Moderate human evidence
Read molecule fact sheet
In clinical trials

Ketone metabolite and precursor formulations

Ketone esters and beta-hydroxybutyrate

Compounds that raise circulating ketones reliably but have not established cognitive or healthy-aging benefit.

Cognition and brainHealthy aging
Early human evidence
Read molecule fact sheet